Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02593916 · ClinicalTrials.gov registry record
Response to Medication Registry
A clinical trial of Adverse Drug Events, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 196
- Enrollment target
- 1
- Study location
NCT02593916 is a study of Adverse Drug Events that has completed, run by Intermountain Health Care. The registered enrollment target is 196 participants, below the 757-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02593916, a study of Adverse Drug Events, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 196 participants
- Enrollment target
- 1
- Study location
Study Summary
To create a registry/database of patients who either have taken drugs that treat cardiovascular conditions or that have presented with cardiovascular symptoms that may be related to medication.
Conditions Studied
Study Locations (1)
Utah
- LDS Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2007-03 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02593916
The ClinicalTrials.gov registry entry for NCT02593916 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 757-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (74% lower). The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Adverse Drug Events appearing as the primary indexed condition, and to 0 interventions.
NCT02593916 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT02593916 about?
NCT02593916 is a clinical study titled "Response to Medication Registry". To create a registry/database of patients who either have taken drugs that treat cardiovascular conditions or that have presented with cardiovascular symptoms that may be related to medication.
What is the current status of trial NCT02593916?
This trial is currently completed. The enrollment target is 196 participants. The study started on 2007-03. Estimated completion is 2018-12.
What conditions does trial NCT02593916 study?
This clinical trial studies the following conditions: Adverse Drug Events.
Who is sponsoring clinical trial NCT02593916?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02593916 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Drug Events
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Multi-Center Medication Reconciliation Quality Improvement Study
COMPLETED · NA
-
Improving Safety by Basic Computerizing Outpatient Prescribing
COMPLETED · Phase 2
-
Patient Profiling and Provider Feedback to Reduce Adverse Drug Events
COMPLETED · NA
-
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
COMPLETED · NA
-
Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.